If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,886.00    -54.00 (-1.84%)
Bid:
2,884.00
Ask:
2,888.00
Spread: 4.00 (0.139%)
Market Cap: £6.84b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Director/PDMR Shareholding

11 Feb 2015 14:19

RNS Number : 6574E
IMI PLC
11 February 2015
Β 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4.

Β 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

Β 

Please complete all relevant boxes in block capital letters.

Β 

1. Name of the issuer

Β 

IMI plc

Β 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R,; (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006)

Β 

Disclosure relates to point (i)

Β 

3. Name of person discharging managerial responsibilities/director

Mark Selway

-

Chief Executive

Douglas Hurt

-

Finance Director

Roy Twite

-

Divisional Managing Director, Critical Engineering

Paul Roberts

-

Group Business Development Director

Β 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Β 

N/A

Β 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

Β 

Notification in respect of persons named in 3 above

Β 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

Ordinary Shares of 28 4/7p each

Β 

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

Β 

Mark Selway

-

8,914

Douglas Hurt

-

188,994

Roy Twite

-

117,298

Paul Roberts

-

7,154

Β 

8. State the nature of the transaction

Β 

Shares purchased pursuant to participation in the IMI Employee Share Ownership Plan

Β 

9. Number of shares, debentures or financial instruments relating to shares acquired

Β 

Mark Selway

-

9

Douglas Hurt

-

9

Roy Twite

-

9

Paul Roberts

-

9

Β 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

Mark Selway

-

0.000003%

Douglas Hurt

-

0.000003%

Roy Twite

-

0.000003%

Paul Roberts

-

0.000003%

Β 

11. Number of shares, debentures or financial instruments relating to shares disposed

Β 

N/A

Β 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)Β 

Β 

N/A

Β 

13. Price pershare or value of transaction

Β 

Β£13.77

Β 

14. Date and place of transaction

Β 

10 February 2015, London

Β 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

Mark Selway

8,923

-

0.003%

Douglas Hurt

189,003

-

0.07%

Roy Twite

117,307

-

0.04%

Paul Roberts

7,163

-

0.003%

Β 

16. Date issuer informed of transaction

Β 

11 February 2015

Β 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

Β 

17. Date of grant

Β 

N/A

Β 

18. Period during which or date on which exercisable

Β 

N/A

Β 

19. Total amount paid (if any) for grant of the option

Β 

N/A

Β 

20. Description of shares or debentures involved (class and number)

Β 

N/A

Β 

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Β 

N/A

Β 

22. Total number of shares or debentures over which options held following notification

Β 

N/A

Β 

23. Any additional information

Β 

N/A

Β 

24. Name of contact and telephone number for queries

Β 

J O'Shea - Legal & Compliance Director and Company Secretary - 0121 717 3700

Β 

Name of authorised official of issuer responsible for making notification

Β 

J O'Shea - Legal & Compliance Director and Company Secretary

Β 

Date of notification

Β 

11 February 2015

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSSFAFLFFISEFE
Date   Source Headline
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 202611:49 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20262:04 pmRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20269:41 amRNSTotal Voting Rights
1st Apr 20267:56 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20266:31 pmRNSDirector/PDMR Shareholding
31st Mar 20269:10 amRNSAnnual Financial Report
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20262:24 pmRNSHolding(s) in Company
23rd Mar 20268:51 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20264:41 pmRNSDirector Declaration
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20262:08 pmRNSDirector/PDMR Shareholding
9th Mar 20267:05 amRNSShare repurchase programme
6th Mar 20267:00 amRNSFull Year Results
2nd Mar 20269:43 amRNSTotal Voting Rights
11th Feb 202612:08 pmRNSDirector/PDMR Shareholding
2nd Feb 202610:32 amRNSTotal Voting Rights
29th Jan 20263:38 pmRNSHolding(s) in Company
14th Jan 20261:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.